Email updates

Keep up to date with the latest news and content from Implementation Science and BioMed Central.

Open Access Research

Reengineering the clinical research enterprise to involve more community clinicians

Gery Ryan1, Claude Berrebi1, Megan Beckett1, Stephanie Taylor16, Elaine Quiter7, Michelle Cho8, Harold Pincus234 and Katherine Kahn15*

Author Affiliations

1 RAND Health, Santa Monica, CA, USA

2 RAND-University of Pittsburgh Health Institute, Pittsburgh, PA, USA

3 Department of Psychiatry, Columbia University, New York, NY, USA

4 New York-Presbyterian Hospital, New York, NY, USA

5 David Geffen School of Medicine at UCLA, Department of Medicine, Los Angeles, CA, USA

6 US Department of Veterans Affairs, Health Services Research and Development Office, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA

7 UCLA School of Public Health, Community Health Sciences, Los Angeles, CA, USA

8 Compass Lexecon, Oakland, CA, USA

For all author emails, please log on.

Implementation Science 2011, 6:36  doi:10.1186/1748-5908-6-36

Published: 4 April 2011

Abstract

Background

The National Institutes of Health has called for expansion of practice-based research to improve the clinical research enterprise.

Methods

This paper presents a model for the reorganization of clinical research to foster long-term participation by community clinicians.

Based on the literature and interviews with clinicians and other stakeholders, we posited a model, conducted further interviews to test the viability of the model, and further adapted it.

Results

We propose a three-dimensional system of checks and balances to support community clinicians using research support organizations, community outreach, a web-based registry of clinicians and studies, web-based training services, quality audits, and a feedback mechanism for clinicians engaged in research.

Conclusions

The proposed model is designed to offer a systemic mechanism to address current barriers that prevent clinicians from participation in research. Transparent mechanisms to guarantee the safety of patients and the integrity of the research enterprise paired with efficiencies and economies of scale are maintained by centralizing some of the functions. Assigning other responsibilities to more local levels assures flexibility with respect to the size of the clinician networks and the changing needs of researchers.